Latest Articles

  • Inpatient glycemic management in noncritically ill patients: Updated guidelines
    Michelle D. Lundholm, MD and Oscar L. Morey-Vargas, MD
    Cleveland Clinic Journal of Medicine October 2023, 90 (10) 615-618; DOI: https://doi.org/10.3949/ccjm.90a.23049

    The guidelines include a role for newer diabetes technologies and nontraditional insulin and noninsulin therapies.

  • In Reply: A new paradigm for adult ADHD
    Michael J. Manos, PhD and Elizabeth J. Short, PhD
    Cleveland Clinic Journal of Medicine October 2023, 90 (10) 593; DOI: https://doi.org/10.3949/ccjm.90c.10003
  • What is the most appropriate management of patients with acute decompensated heart failure who develop in-hospital hypotension?
    Lorenzo Braghieri, MD, Warren A. Skoza, MD, Osamah Z. Badwan, MD and Paulino Alvarez, MD
    Cleveland Clinic Journal of Medicine October 2023, 90 (10) 625-631; DOI: https://doi.org/10.3949/ccjm.90a.22095

    The authors offer a tailored approach to risk-stratification in these patients that focuses on early recognition and management of symptomatic and clinically significant hypotension.

  • Masked tinea
    Ayano Hamai, MD and Yukinori Harada, MD, PhD
    Cleveland Clinic Journal of Medicine October 2023, 90 (10) 601-602; DOI: https://doi.org/10.3949/ccjm.90a.23002

    A result of daily mask-wearing during a long hospitalization.

  • Portopulmonary hypertension: A focused review for the internist
    Portopulmonary hypertension: A focused review for the internist
    Mamta S. Chhabria, MD, Leela Krishna Teja Boppana, MD, Gaurav Manek, MD and Adriano R. Tonelli, MD, MSc
    Cleveland Clinic Journal of Medicine October 2023, 90 (10) 632-639; DOI: https://doi.org/10.3949/ccjm.90a.23023

    Key aspects of screening, diagnosis, and treatment, and a review of the various pulmonary hemodynamic patterns encountered in patients with liver disease.

  • A new paradigm for adult ADHD
    Uche Nkanginieme, Medical student
    Cleveland Clinic Journal of Medicine October 2023, 90 (10) 592-593; DOI: https://doi.org/10.3949/ccjm.90c.10002
  • Should I start an SGLT-2 inhibitor in my patient with heart failure and chronic kidney disease?
    Richard Sekerak, MD, Johanna Ben-Ami Lerner, MD, Pooja Prasad, MD and Megha Prasad, MD
    Cleveland Clinic Journal of Medicine October 2023, 90 (10) 607-609; DOI: https://doi.org/10.3949/ccjm.90a.23004

    These conditions often co-exist and can have complex interactions. The progression of kidney disease increases the risk of major adverse cardiovascular events.

  • Evaluating a low anion gap: A practical approach
    Lawrence A. Haber, MD, Gurpreet Dhaliwal, MD, Lowell Lo, MD and Gabrielle Rizzuto, MD, PhD
    Cleveland Clinic Journal of Medicine October 2023, 90 (10) 619-623; DOI: https://doi.org/10.3949/ccjm.90a.23035

    In teaching and in practice, little attention is given to a low anion gap, an oversight that can result in a missed opportunity to diagnose acute or chronic disorders requiring treatment.

  • Should midodrine be used as an intravenous vasopressor-sparing agent in septic shock?
    Simran Gupta, MD, Ayan Sen, MD and Aman Verma, DO
    Cleveland Clinic Journal of Medicine October 2023, 90 (10) 603-605; DOI: https://doi.org/10.3949/ccjm.90a.23040

    Research and robust data are still lacking regarding use of midodrine in this setting.

  • vOka vaccine-associated disseminated varicella zoster
    Peter R. Hyson, MD and Louis B. Polish, MD
    Cleveland Clinic Journal of Medicine October 2023, 90 (10) 599-600; DOI: https://doi.org/10.3949/ccjm.90a.23008

    The patient had received the live attenuated vaccine 1 month before presentation. He had no history of varicella infection.

Pages